Document Detail

Improvement in functional recovery of stunned canine myocardium by long-term pretreatment with oral propranolol.
MedLine Citation:
PMID:  2929396     Owner:  NLM     Status:  MEDLINE    
We investigated the effect of long-term oral pretreatment with the beta-adrenergic antagonist, propranolol (Inderal LA, 160 mg daily for 8 days) on the functional recovery of myocardium after 15-minute coronary artery occlusion followed by 3 hours of reperfusion in barbital-anesthetized dogs. Propranolol-pretreated dogs (N = 9) displayed a significantly lower left ventricular peak-positive rise in ventricular pressure (dP/dt), heart rate, and rate-pressure product throughout the experiment compared with the control group (N = 15). Subendocardial percent segment shortening as measured by sonomicrometry recovered to 65.4 +/- 7.2% of the preocclusion level after pretreatment with propranolol, whereas the control group recovered to only 11.1% +/- 10.2% after 3 hours of reperfusion. To ascertain the beneficial role of a lower heart rate on the recovery of regional contractile function, a third group of dogs (N = 6) was pretreated with propranolol, but heart rate was maintained at control levels by atrial pacing. The beneficial effects of pretreatment with propranolol were abolished in this group. There were no differences between groups in myocardial perfusion in the normal region as measured by the radioactive microsphere technique. However, in postischemic, reperfused myocardium, there was a significantly higher blood flow to subepicardium, mid-myocardium, and subendocardium after reperfusion in the propranolol-pretreated, unpaced group. Thus long-term oral pretreatment with propranolol enhances the contractile recovery of postischemic, reperfused myocardium. This protective effect of beta-adrenergic blockade is primarily related to the reduction in heart rate and enhanced perfusion in the postischemic region.
M H al-Wathiqui; N Farber; L Pelc; G J Gross; H L Brooks; D C Warltier
Related Documents :
17532966 - Efficacy of mci-186, a free-radical scavenger and antioxidant, for resuscitation of non...
6373306 - Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after corona...
18067666 - Length of pressure-controlled reperfusion is critical for reducing ischaemia-reperfusio...
9769236 - Modulation of adenosine effects in attenuation of ischemia and reperfusion injury in ra...
2166736 - Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypo...
16522996 - Systemic inflammation, blood pressure, and stroke outcome.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American heart journal     Volume:  117     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1989 Apr 
Date Detail:
Created Date:  1989-05-03     Completed Date:  1989-05-03     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  791-8     Citation Subset:  AIM; IM    
Department of Pharmacology, Medical College of Wisconsin, Milwaukee 53226.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Blood Pressure / drug effects
Coronary Circulation / drug effects*
Coronary Disease / physiopathology*
Heart Rate / drug effects
Myocardial Contraction / drug effects*
Myocardial Reperfusion
Propranolol / administration & dosage*,  blood,  pharmacology
Grant Support
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Surgical treatment of multiple aneurysms. Review of experience with 372 cases.
Next Document:  Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury f...